Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Procalcitonin in early allograft dysfunction after orthotopic liver transplantation: a retrospective single centre study

Fig. 3

Kaplan Meier Analysis of graft and patient survival of non-IRI patients and IRI patients with PCT > 15 mcg/l versus IRI patients with PCT < 15 mcg/l. Panel A. 12-month graft survival of non-IRI patients was 56/64 (87.5%). 12-month graft survival of IRI patients with PCT > 15 mcg/l did not differ from that of non-IRI patients (25/27 (92.6%); p=0.483) and was lower in IRI patients with PCT < 15 mcg/l (11/19 (57.9%); p=0.002). Panel B. 12-month patient survival of non-IRI patients was 56/64 (87.5%). 12-month patient survival of IRI patients with PCT > 15 mcg/l did not differ from that of non-IRI patients (25/27 (92.6%); p = 0.483) and was lower in IRI patients with PCT < 15 mcg/l (13/19 (68.4%); p = 0.034)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us